Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -595,625 | -375,014 | -208,076 | -31,164 | -823,605 |
| Depreciation Amortization | 200,556 | 163,644 | 93,919 | 45,770 | 376,123 |
| Income taxes - deferred | -253,169 | -248,716 | -244,509 | -243,130 | -6,748 |
| Accounts receivable | 25,150 | -14,038 | 8,995 | -22,950 | -100,526 |
| Accounts payable and accrued liabilities | 169,800 | 64,344 | 27,138 | -15,862 | 55,165 |
| Other Working Capital | 111,109 | 17,247 | 33,211 | -37,667 | -42,269 |
| Other Operating Activity | 239,943 | 314,869 | 252,432 | 227,776 | 678,342 |
| Operating Cash Flow | $-102,236 | $-77,664 | $-36,890 | $-77,227 | $136,482 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -369,728 | -596,727 | -589,909 | 73,797 | -203,278 |
| PPE Investments | -193,839 | -134,447 | -95,577 | -37,920 | -476,499 |
| Net Acquisitions | -499,730 | -415,549 | -415,549 | -343,248 | -6,658 |
| Purchase Of Investment | -18,044 | -13,555 | -10,000 | -10,000 | -15,947 |
| Other Investing Activity | -744 | -244 | -244 | -141 | 345 |
| Investing Cash Flow | $-1,082,085 | $-1,160,522 | $-1,111,279 | $-317,512 | $-702,037 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,125,547 |
| Debt Repayment | N/A | N/A | N/A | N/A | -150,054 |
| Common Stock Issued | 37,507 | 25,410 | 23,655 | 8,759 | 907,133 |
| Other Financing Activity | -29,035 | -4,742 | -3,068 | -1,514 | -3,005 |
| Financing Cash Flow | $8,472 | $20,668 | $20,587 | $7,245 | $1,879,621 |
| Exchange Rate Effect | 23 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,491,594 | 1,491,594 | 1,491,594 | 1,491,594 | 177,528 |
| End Cash Position | 315,768 | 274,076 | 364,012 | 1,104,100 | 1,491,594 |
| Net Cash Flow | $-1,175,826 | $-1,217,518 | $-1,127,582 | $-387,494 | $1,314,066 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,236 | -77,664 | -36,890 | -77,227 | 136,482 |
| Capital Expenditure | -193,839 | -134,447 | -95,577 | -37,920 | -476,499 |
| Free Cash Flow | -296,075 | -212,111 | -132,467 | -115,147 | -340,017 |